Abstract
The article studies the domestic market of vasodilators for cardiac diseases in Belarus by analyzing and comparing secondary marketing information. The structure of the market depending on the manufacturing country was studied. It was established that medicines containing isosorbide mononitrate/dinitrate have the greatest number of indications to use and the least number of side effects. The dynamics of changing the sales of medicines in the vasodilators group for cardiac diseases for the period 2010-2018 is presented. The market attractiveness of medicines of the vasodilators group for cardiac diseases was studied using the matrix of the Boston Consulting Group (BCG matrix).
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
